Professional Documents
Culture Documents
Heterocycles Nomenclature
Heterocycles Nomenclature
3 2 3 2 4 5 4 5 2 1 3 4 5 6 5 7 4 3
Heterocyclic Chemistry
4 5 4 3 2 3 4 5
N N1
4 5 6
6 7 8
N1 H
NH
6 7 1
N1 H
N9 H
N
1
N1 H
4
HN
N1 H
6 7
2-Pyrazoline
5
N1 H
5 4
N
1
N
2
Pyrazolidine
6 7 8 1
Quinazoline
N3 N2
3 2N
Cinnoline
3 4 5
N1
Isoindole
8 1 2 5
3H-Indole
4 3
N1 H
N N
N N1
N
2
N N1
6
N1 H
N1
3-Pyrroline 2H-Pyrrole
3 2 4 5 5 2 6 7 4 3 5 4 3
N1 H
N
5 4 3
N1 H
N1
4 5 6
Pteridine
H N
4 5 6 6 7
Phthalazine
5
2-Pyrroline
4
Indolizine
4 5 3 2 5
N1
3 2
4 3 2
4 3 5
N 2 N
2
N1
O
6 7 1
3 2
O1
O1
O1
O1
S1
S1
Piperazine
N1 H
N1
6 7
N10
N1 H
Quinoxaline
Phenazine OMe 3.3 4.9 6.6 SMe 3.6 4.4 6.0 Cl 0.7 2.8 3.8 Ph 4.5 4.8 5.5 vinyl 4.8 4.8 5.5
1H-Indazole
Isobenzofuran
8 7 3 4 5
2H-Pyran
9 8 7
4H-Pyran
1 2
4 3 2 5
N1
N1 H
6 2
N
1
N
6 5 4
N2
5 6 7 8
4 3 2
Effects of Substitution on Pyridine Basicity: Me tBu NH2 NHAc 4 3 2-position 6.0 5.8 6.9 4.1 3-position 5.7 5.9 6.1 4.5 2 N1 4-position 6.0 6.0 9.2 5.9 Lithiation Positions: First, Second
N N Me N S S S N O O
4H-Quinolizine
5 4 3 6 2 7 8 5
N1
N10
N1 H
N1
thermodynamic
N Me
N R
kinetic
N O1
4 5 2
4 5
3 5 2 6
N S1
4 5
O1
6 7
O1
S1
S1
Isoxazole pKa: 3
3 2 4
N N1 H
N N S1
4 5
N N N1 H
4 5
2 5
3 2
N N1 H
4 5
6 7
N H
3 2 1N 6
N1 H
9 8
HN
2
4 5 2
N N N1 H
4 5
N N O1
4 2 5
N N1 H
4 5
N7 H
N1 H
Imidazolidine
4 3 2 3 2 5 6 7 8 9
1,2,3-Oxadiazole
3 4
43 37 45
S
2 4 3S 5
S S1
6
3 2
4 5 6 3 2
4 5 6 3 2
Phenothiazine
O O1
4 3 5 2
N 10 H
S1
H4 N O1
1,3,5-Trithiane
4 3 2 1
1,4-Dithiane
5 6 7 8 9
5 6
O1
H4 N S1
2 5 6
1,4-Dioxane
S1
1,3-Dithiane pKa: 31
1,3-Dioxolane
Thiomorpholine
Phenoxazine
N 10 H
0.049 12 ED50: Dose required to yield maximum therapeutic effect in 50% of test animals. Efficacy: Description of the relative intensity with which agonists vary in the response they produce, even with similar affinity. Homologue: A compound belonging to a series of compounds differing from each other by a repeating unit (i.e. a CH2, a peptide residue, etc.). Intrinsic activity: The maximal stimulatory response induced by a compound relative to that of a given reference comopund. LD50: Dose required to kill 50% of test animals. Partition coefficient (LogP): Log10 of the ratio of a compound's concentration in 1-octanol vs. water at equilibrium. A LogP<0 means that a compound is more soluble in water than in 1-octanol. Pharmacophore: The ensemble of steric and electronic features that is necessary to ensure the optimal supramolecular interactions with a specific biological target structure and to trigger (or block) its biological response. This is not a real molecule or moiety, but rather an abstract concept that is considered the largest common denominator shared by a set of active molecules. Potency: The dose of a drug required to produce a specific effect of given intensity as compared to a standard reference. Therapeutic index: LD50/ED50
Baran, Richter
Indoles:
O
Heterocyclic Chemistry
R' O O COY R' Y R N H X
Pyrroles:
R R' NO2
CN CO2X
N H
NH2
R'
+
R NH2
S N H R
nBu SnH 3
Me
R' R' N+
AIBN
X Ph
Huisgen Pyrrole Synthesis MeO RNH2 PdII N R Me MeO2C N N CO2Me OMe Zn HOAc MeO2C Boger Pyrrole Synthesis Me H2NNH2 O CoI2, Me Et Et N H Piloty Pyrrole Synthesis R Br O R2 R1 CO2Me N H R2 R1 R N H
Pd(OAc)2, base
Me R1 N H R R NO2
+
BrMg R1
+
H2N
Me
Bartoli Indole Synthesis X R X = OH, NH2 Bucherer Carbazole Synthesis R3 R N R1 O R2 Base R N R1 R2 R R3 O i. PhNHNH2 NaHSO3, ii. H+ R
Thiophenes:
Me P4S10 Me S Me HS CO2Me i. DMAD, piperidine ii. NaOMe OH CO2Me
R2
R2 HO
+
O
Ph
+
X
+
NH2
I NH2
CO2R N3
H+ CO2R N H
Ni0 N R
HN R O
CO2H
Ac2O R
N O
Cornforth Rearrangement